Avidity Biosciences, Inc. (RNA) Insider Trading -- Recent Executive & Director Transactions
21 insiders reported 119 Form 4 transactions for Avidity Biosciences, Inc. (RNA) over the past 18 months (most recent 2026-09-22). Recent activity: Hughes Steven George (Chief Medical Officer) Sell 21,459 shares, Kenney Stephanie (Chief Corporate Affairs Officer) Sell 2,375 shares, Flanagan W. Michael (Director) Sell 22,812 shares, Gallagher Kathleen P. (Chief Executive Officer and President) Sell 11,632 shares, Boyce Sarah (Director) Sell 126,418 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Hughes Steven George | Chief Medical Officer | Sell | 21,459 | $192,058 |
| 2026-09-22 | Kenney Stephanie | Chief Corporate Affairs Officer | Sell | 2,375 | $21,256 |
| 2026-09-22 | Flanagan W. Michael | Director | Sell | 22,812 | $204,167 |
| 2026-09-22 | Gallagher Kathleen P. | Chief Executive Officer and President | Sell | 11,632 | $104,106 |
| 2026-09-22 | Boyce Sarah | Director | Sell | 126,418 | $1.1M |
| 2026-09-22 | Winslow Brendan R. | Chief Financial Officer | Sell | 6,742 | $60,341 |
| 2026-09-22 | Hoyos Rocio Martin | Chief Strategy Officer | Sell | 8,320 | $74,464 |
| 2026-09-22 | Younis Husam | Chief Scientific Officer | Sell | 11,216 | $100,383 |
| 2026-04-22 | Gallagher Kathleen P. | Chief Executive Officer and President | Buy | 102,500 | $0 |
| 2026-04-22 | Younis Husam | Chief Scientific Officer | Buy | 30,000 | $0 |
| 2026-04-22 | Hoyos Rocio Martin | Chief Strategy Officer | Buy | 30,000 | $0 |
| 2026-04-22 | Kenney Stephanie | Chief Corporate Affairs Officer | Buy | 30,000 | $0 |
| 2026-04-22 | Hughes Steven George | Chief Medical Officer | Buy | 30,000 | $0 |
| 2026-04-22 | Winslow Brendan R. | Chief Financial Officer | Buy | 30,000 | $0 |
| 2026-01-23 | Boyce Sarah | President and CEO | Sell | 7,993 | $579,093 |
| 2026-01-23 | MacLean Michael F | Chief Financial Officer | Sell | 1,807 | $130,917 |
| 2026-01-23 | MacLean Michael F | Chief Financial Officer | Sell | 2,735 | $198,151 |
| 2026-01-23 | LEVIN ARTHUR A | Director | Sell | 1,758 | $127,367 |
| 2026-01-23 | McCarthy Teresa | Chief Human Resources Officer | Sell | 1,476 | $106,936 |
| 2026-01-23 | McCarthy Teresa | Chief Human Resources Officer | Sell | 1,453 | $105,270 |
| 2026-01-23 | Flanagan W. Michael | Chief Scientific Officer | Sell | 2,558 | $185,327 |
| 2026-01-23 | Hughes Steven George | Chief Medical Officer | Sell | 2,017 | $146,132 |
| 2026-01-23 | Hughes Steven George | Chief Medical Officer | Sell | 2,878 | $208,511 |
| 2026-01-23 | Boyce Sarah | President and CEO | Sell | 6,394 | $463,245 |
| 2026-01-23 | Flanagan W. Michael | Chief Scientific Officer | Sell | 3,976 | $288,061 |
Source: SEC Form 4 filings · as of 2026-09-22